VPC-13789

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

VPC-13789

VPC-13789 是一种口服有效的选择性抗雄激素。VPC-13789 可用于研究去势抵抗性前列腺癌 (CRPC) 。VPC-13789 抑制 LNCaP 细胞中的雄激素受体 (AR) 转录活性 (IC₅₀=0.19 μM)。

VPC-13789 Chemical Structure

CAS No. : 2761146-51-2

* Please select Quantity before adding items.

生物活性	VPC-13789 is a potent, selective, and orally bioavailable antiandrogen. VPC-13789 can be used for the research of castration-resistant prostate cancer (CRPC) therapeutics. VPC-13789 inhibits androgen receptor (AR) transcriptional activity in LNCaP cells (IC₅₀=0.19 μM)^[1].
分子量	383.37
Formula	C₂₁H₁₆F₃N₃O
CAS 号	2761146-51-2
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
参考文献	[1]. Eric Leblanc , et al. Development of 2-(5,6,7-Trifluoro-1 H-Indol-3-yl)-quinoline-5-carboxamide as a Potent, Selective, and Orally Available Inhibitor of Human Androgen Receptor Targeting Its Binding Function-3 for the Treatment of Castration-Resistant Prostate Cancer. J Med Chem. 2021 Oct 28;64(20):14968-14982.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务

whatman (沃特曼)